Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

Ticagrelor (BRILINTA) 90 mg: Ticagrelor (BRILINTA) 90 mg is indicated for the prevention of thrombotic events (cardiovascular death, myocardial infarction and stroke) in patients with Acute Coronary Syndromes (ACS) (unstable angina, non-ST elevation Myocardial Infarction [NSTEMI] or ST elevation Myocardial Infarction [STEMI]) including patients managed medically, and those who are managed with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).
Ticagrelor (BRILINTA) 90 mg is indicated for the prevention of stroke in patients with Acute Ischaemic Stroke or Transient Ischaemic Attack (TIA).

Brilinta Indications/Uses

Manufacturer:

AstraZeneca

Distributor:

Zuellig